Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia

od He, Bai‐Liang, Yang, Ning, Man, Cheuk Him, Ng, Nelson Ka‐Lam, Cher, Chae‐Yin, Leung, Ho‐Ching, Kan, Leo Lai‐Hok, Cheng, Bowie Yik‐Ling, Lam, Stephen Sze‐Yuen, Wang, Michelle Lu‐Lu, Zhang, Chun‐Xiao, Kwok, Hin, Cheng, Grace, Sharma, Rakesh, Ma, Alvin Chun‐Hang, So, Chi‐Wai Eric, Kwong, Yok‐Lam, Leung, Anskar Yu‐Hung
Wydane w EMBO Mol Med (2020)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia

od He, Bai‐Liang, Yang, Ning, Man, Cheuk Him, Ng, Nelson Ka‐Lam, Cher, Chae‐Yin, Leung, Ho‐Ching, Kan, Leo Lai‐Hok, Cheng, Bowie Yik‐Ling, Lam, Stephen Sze‐Yuen, Wang, Michelle Lu‐Lu, Zhang, Chun‐Xiao, Kwok, Hin, Cheng, Grace, Sharma, Rakesh, Ma, Alvin Chun‐Hang, So, Chi Wai Eric, Kwong, Yok‐Lam, Leung, Anskar Yu‐Hung
Wydane w EMBO Mol Med (2020)

Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response

od Chakraborty, Saborni, Gonzalez, Joseph C., Sievers, Benjamin L., Mallajosyula, Vamsee, Chakraborty, Srijoni, Dubey, Megha, Ashraf, Usama, Cheng, Bowie Yik-Ling, Kathale, Nimish, Tran, Kim Quyen Thi, Scallan, Courtney, Sinnott, Aanika, Cassidy, Arianna, Chen, Steven T., Gelbart, Terri, Gao, Fei, Golan, Yarden, Ji, Xuhuai, Kim-Schulze, Seunghee, Prahl, Mary, Gaw, Stephanie L., Gnjatic, Sacha, Marron, Thomas U., Merad, Miriam, Arunachalam, Prabhu S., Boyd, Scott D., Davis, Mark M., Holubar, Marisa, Khosla, Chaitan, Maecker, Holden T., Maldonado, Yvonne, Mellins, Elizabeth D., Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Subramanian, Aruna, Utz, Paul J., Sherwood, Robert, Zhang, Sheng, Jagannathan, Prasanna, Tan, Gene S., Wang, Taia T.
Wydane w bioRxiv (2021)